HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hélène Zattara Selected Research

Cutaneous Malignant Melanoma

7/2008The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hélène Zattara Research Topics

Disease

4Melanoma (Melanoma, Malignant)
01/2019 - 07/2008
2Hematologic Neoplasms (Hematological Malignancy)
12/2016 - 09/2011
1Medulloblastoma
11/2020
1Nevus (Nevi)
01/2019
1Tetraploidy
01/2018
1Neoplasms (Cancer)
12/2016
1Carcinogenesis
10/2011
1Hypoxia (Hypoxemia)
10/2011
1Kidney Neoplasms (Kidney Cancer)
10/2011
1Leukemia
09/2011
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
09/2011
1Lymphoma (Lymphomas)
09/2011
1Cutaneous Malignant Melanoma
07/2008

Drug/Important Bio-Agent (IBA)

2Cyclin-Dependent Kinase Inhibitor p16IBA
12/2012 - 07/2008
2Proteins (Proteins, Gene)FDA Link
09/2011 - 07/2008
1CateninsIBA
11/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1Phenobarbital (Luminal)FDA Link
01/2018
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
12/2016
1Mutant Proteins (Protein, Mutant)IBA
10/2011
1Microphthalmia-Associated Transcription FactorIBA
10/2011
1PerforinIBA
09/2011
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
07/2008
1Cell Cycle ProteinsIBA
07/2008

Therapy/Procedure

1Ligation
07/2008